HYPR Incorporates a Nanoparticle into Liquid Resin at the Molecular Level, Modifying the Strength of Plastics by 30% or more. Future Production of Biomedical Components, Devices and Reinforced Bio-based Polymers.

Business Model:
Initial Focus is on Securing Out-Licensing Agreements (Additives Formulation & Process) with Major Plastic Manufacturers. Future Revenue Streams will come from Production of Proprietary Components & Devices.